Trade Quest Diagnostics - DGX
Founded in 1967, Quest Diagnostics (DGX) is the leading global provider of diagnostic information services. Headquartered in Madison, New Jersey, the company has a team of 43,000 employees that operate 2,200 patient service centres across the country. Annually, Quest serves one in three adult Americans and half the hospitals and physicians in the USA. Quest Diagnostics delivers diagnostic testing services for neurological disorders, cardiovascular disease, infectious diseases and cancer. With an annual revenue of $7.5 billion the company is included to the S&P 500 index. The Quest Diagnostics share price (DGX) is set and traded on the New York Stock Exchange (NYSE).Latest shares articles

Buzzi stock forecast: H1 EBITDA and margin pressure
Buzzi is an Italian building-materials group listed in Milan, with recent trading shaped by a September share-price decline and a new investor presentation. Explore third-party BZU price targets and technical analysis. Past performance is not a reliable indicator of future results.
11:07, 25 September 2026

PKO BP stock forecast: POLSTR mortgages, KNF penalties
PKO Bank Polski introduced POLSTR 1M-linked mortgages from 3 September and is seeking reconsideration of five KNF penalties totalling 47.5m PLN. Explore third-party PKO price targets and technical analysis. Past performance is not a reliable indicator of future results.
11:40, 24 September 2026

Soitec stock forecast: €500m ORNANE bond
Soitec is a French semiconductor materials company. In September 2026, it placed €500m of 0.5% ORNANEs due in 2033, with settlement expected on 25 September. Explore third-party SOI price targets and technical analysis. Past performance is not a reliable indicator of future results.
10:51, 24 September 2026

Vossloh stock forecast: RTI acquisition expands digital rail
Vossloh is a German rail-infrastructure group that completed its acquisition of Rail Technology International on 15 September, expanding its digital inspection and analytics offering. Explore third-party VOS price targets. Past performance is not a reliable indicator of future results.
11:09, 23 September 2026
Related News
GlobeNewswire•Europe
Public Technologies•Europe